Skip to Content
Merck
CN
  • Linoleic acid supplementation of Barth syndrome fibroblasts restores cardiolipin levels: implications for treatment.

Linoleic acid supplementation of Barth syndrome fibroblasts restores cardiolipin levels: implications for treatment.

Journal of lipid research (2003-02-04)
F Valianpour, R J A Wanders, H Overmars, F M Vaz, P G Barth, A H van Gennip
ABSTRACT

The object of this study was to investigate whether the levels of cardiolipin in cultured skin fibroblasts of patients with Barth syndrome (BTHS) can be restored by addition of linoleic acid to growth media. To this end, fibroblasts from controls and BTHS patients were grown in the presence or absence of linoleic acid. High-performance liquid chromatography-electrospray ionization tandem mass spectrometry was used for quantitative and compositional analysis of cardiolipin. Incubation of cells from both BTHS and controls with different concentrations of linoleic acid led to a dose- and time-dependent increase of cardiolipin levels. The increased levels of cardiolipin in fibroblasts of BTHS patients after treatment with linoleic acid indicate that an increased amount of linoleic acid in the diet might be beneficial to BTHS patients.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Linoleic acid, technical, 58-74% (GC)
Sigma-Aldrich
Linoleic acid, liquid, BioReagent, suitable for cell culture
Supelco
Linoleic acid, analytical standard
Sigma-Aldrich
Linoleic acid, ≥99%